BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Liver, Avian flu virus, Trichostatin A, rs7903146, IGF1, Angiogenesis, Hepatitis)
Bookmark Forward

QuickView for Pum2;jsessionid=4C532D11AEB30DB7AE74A1F45D73B334;jsessionid=EB6FA8938369463272BC38C1866B2A0C;jsessionid=32C0F89546A511DDF54598E6ACCA9726 (gene)


Body Atlas

Most Correlated Tissues

  1. Basophil of peripheral blood
  2. T Lymphocyte (regulatory) of peripheral blood
  3. Eosinophil of peripheral blood
  4. T Lymphocyte (CD4+) of peripheral blood
  5. Natural killer cell of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Poisoning by drug AND/OR medicinal substance
  2. Toxic nephropathy
  3. Hemoglobinopathy
  4. Disease caused by parasite
  5. Caseating tuberculoid granuloma
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 3-chloroaniline
  2. hexachloroethane
  3. nitrobenzene
  4. nateglinide
  5. Chlorpyrifos
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. 42313
  2. PUM2
  3. MCF2L
  4. PUM1
  5. TYROBP
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. PUM2 regulates the formation of thoracic aortic dissection through EFEMP1.
  2. PUMILIO proteins promote colorectal cancer growth via suppressing p21.
  3. The BMSC-derived exosomal lncRNA Mir9-3hg suppresses cardiomyocyte ferroptosis in ischemia-reperfusi…
  4. PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and c…
  5. NORAD-induced Pumilio phase separation is required for genome stability.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for Pum2;jsessionid=4C532D11AEB30DB7AE74A1F45D73B334;jsessionid=EB6FA8938369463272BC38C1866B2A0C;jsessionid=32C0F89546A511DDF54598E6ACCA9726
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.